Pinnacle Plans to Scale U.S. Manufacturing Capacity to 25 Million Tests Per Month
Cost-Effective 15-Minute Rapid Antigen Test Demonstrates 100% Specificity for COVID-19 Detection When Compared with RT-PCR
ENGLEWOOD, CO / ACCESSWIRE / September 8, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the “Company”) focused on commercializing novel products that address significant patient needs announced today that the Company has signed an agreement to distribute the Pinnacle